These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31091402)

  • 21. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study.
    Kafatos G; Pebody R; Andrews N; Durnall H; Barley M; Fleming D
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1175-80. PubMed ID: 24103037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
    Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
    BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
    Kissling E; Valenciano M;
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.
    Fielding JE; Grant KA; Tran T; Kelly HA
    Euro Surveill; 2012 Mar; 17(11):. PubMed ID: 22449867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Cowling BJ; Feng S; Finelli L; Steffens A; Fowlkes A
    Vaccine; 2016 Jan; 34(1):61-6. PubMed ID: 26611200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
    Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
    PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.
    Kissling E; Valenciano M;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
    Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ
    Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.
    Jiménez-Jorge S; Pozo F; Larrauri A;
    Vaccine; 2015 Jun; 33(29):3276-80. PubMed ID: 25869892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012.
    Jimenez-Jorge S; de Mateo S; Pozo F; Casas I; Garcia Cenoz M; Castilla J; Gallardo V; Perez E; Vega T; Rodriguez C; Quinones C; Martinez E; Gimenez J; Vanrell J; Castrillejo D; Serrano M; Ramos J; Larrauri A
    Euro Surveill; 2012 Mar; 17(12):. PubMed ID: 22490308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13.
    McMenamin J; Andrews N; Robertson C; Fleming D; Durnall H; von Wissmann B; Ellis J; Lackenby A; Cottrell S; Smyth B; Zambon M; Moore C; Watson J; Pebody R
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network.
    Sullivan SG; Chilver MB; Higgins G; Cheng AC; Stocks NP
    Med J Aust; 2014 Jul; 201(2):109-11. PubMed ID: 25045991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.